Bellicum reports q4 revenue of $5.1 mln

Bellicum reports fourth quarter and full year 2019 financial results and provides operational update.bellicum pharmaceuticals inc - qtrly revenue $5.1 million versus $312,000.bellicum pharmaceuticals inc - qtrly loss per share $5.82.bellicum pharmaceuticals inc - management expects cash utilization of $55 to $65 million in 2020.
BLCM Ratings Summary
BLCM Quant Ranking